CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition
Clinical trial NCT04322955 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04322955
- Sponsor
- Mark Stein
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-22
- Primary completion
- 2027-05-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.